🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST

COSCIENS Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.217.3116.396.6850.6165.3
Cash & Short-Term Investments
9.217.3116.396.6850.6165.3
Cash Growth
8.01%-55.43%145.48%-86.80%-22.50%169.04%
Accounts Receivable
2.361.081.880.130.40.88
Other Receivables
-0.180.590.161.762.8
Receivables
2.361.262.470.292.163.68
Inventory
2.171.312.694.010.230.07
Prepaid Expenses
1.251.41.70.080.430.42
Other Current Assets
-0.220.730.212.061.35
Total Current Assets
14.9911.523.9811.2755.4970.82
Property, Plant & Equipment
9.99.8110.9711.650.220.19
Goodwill
-----8.13
Other Intangible Assets
12.55--0.01-0.63
Long-Term Deferred Tax Assets
---0.08--
Other Long-Term Assets
0.640.130.120.750.320.34
Total Assets
38.0821.4335.0723.7556.0380.1

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.70.752.410.282.040.93
Accrued Expenses
0.11.142.370.731.791.74
Current Portion of Leases
0.320.220.270.30.110.13
Current Income Taxes Payable
00.120.11-0.110.12
Current Unearned Revenue
1.22-0.12-2.954.82
Other Current Liabilities
6.691.391.95-0.050.03
Total Current Liabilities
22.73.617.221.317.047.77
Long-Term Leases
3.111.932.041.40.070.03
Long-Term Unearned Revenue
-1.060.91-1.791.59
Pension & Post-Retirement Benefits
-10.9811.73-11.1617.49
Other Long-Term Liabilities
1.47---0.190.24
Total Liabilities
27.2817.5921.912.7120.2527.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
21.2422.6222.4913.52293.41293.41
Additional Paid-In Capital
----90.33-
Retained Earnings
-12.32-20.51-12.114.36-352.08-334.62
Comprehensive Income & Other
1.881.732.793.164.1294.2
Shareholders' Equity
10.83.8413.1621.0435.7852.99
Total Liabilities & Equity
38.0821.4335.0723.7556.0380.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
14.092.152.311.70.180.16
Net Cash (Debt)
-4.885.1614.084.9850.4365.14
Net Cash Growth
--63.37%182.79%-90.13%-22.58%170.43%
Net Cash Per Share
-4.074.8916.378.0981.58170.04
Filing Date Shares Outstanding
11.061.050.40.40.4
Total Common Shares Outstanding
11.061.050.40.40.4
Working Capital
-7.77.8916.769.9648.4463.05
Book Value Per Share
10.823.6212.5751.9888.41130.94
Tangible Book Value
-1.753.8413.1621.0335.7844.23
Tangible Book Value Per Share
-1.753.6212.5751.9788.41109.30
Machinery
-10.7410.911.980.450.47
Leasehold Improvements
-5.955.646.68--